Frances Gagua

China Bohai Bank faces high asset risk from retail and investment loans

Its NPL ratio rose 5 basis points in June 2025 compared to six months prior.

Kiatnakin Phatra Bank's profit jumps 26.1% but loan book shrinks in Q4 2025

Its net profit of $190.06m is 18.6% higher compared to a year earlier.

Indonesia's Artajasa ties up with Ant International on cross-border payments

Artajasa connects over 80,000 ATMs and 41 million merchants in Indonesia.

India’s ESAF Small Finance Bank modernises onboarding and lending

It expects to optimise IT costs and see lower licensing costs.

CZBANK stays stable but property risks spark new NPL threat

Net interest margin narrowed in 9M 2025, but this is expected to slow, Moody’s said.

Macquarie Bank launches new AI-powered chat agent

It can answer common customers' questions and requests and escalate to a team member.

Siam Commercial Bank to perform maintenance on international fund transfers

SCB Easy App users will not be able to use the service during this period.

OCBC profit expected at $1.7b on higher fee and insurance income

Fee income and insurance contribution are expected to have grown during the quarter.

UOB profit set to slide 16.7% on lower wealth and loan fees

It will take time for UOB to return to its peak profitability, the report said.

Hong Kong expands RMB facility to $28.6b after banks hit quotas

The initial quota had been fully allocated to 40 banks.

Mastercard pushes tokenisation as payments go passive

Transactions fade into the background when there’s  trust.

Bangkok Bank’s net profit up 1.8% to $1.47b in 2025

For the full year, expected credit losses amounted to $1.16b.

Krungsri’s profit rises 6.9% in 2025 as retail and SME loans contract

Its CEO warned of slower economic growth and consumption in 2026.

Mizuho and Fujitsu automate 70% of SME order processing tasks

It streamlines 70% of order processing tasks by elimination manual input and conversion work.

Citi foresees more Asia M&A deals on healthcare and multinational moves

In 2026, Citi already led two M&A biopharma deals in China.

SCB X’s net profit rose 8.1% to $1.51b in 2025

But its loan portfolio contracted and net interest income dropped 8%.